All In Biotech

Drug Trial Radar · NCT00121901

Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography (ERCP) Pancreatitis?

Last checked: Nov 19, 2026Latest source record: Oct 18, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,600 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,600

Planned (sponsor's estimate)

Start

Oct 2004

Primary completion

Not stated

Study completion Oct 2007

Sponsor

Lead sponsor
Hvidovre University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 21, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Post-ERCP pancreatitis can be a serious complication to ERCP. Two studies have shown a promising preventive effect of glyceryl nitrate. This study should provide a final answer to the clinical question: Does glyceryl nitrate prevent post-ERCP pancreatitis? The study is a prospective, randomized, double blind, placebo-controlled multicenter trial. The investigators intend to include 1600 patients from Norway, Sweden, Denmark, and France. The patients will receive either placebo or a glyceryl nitrate patch (15 mg/24 hours). Follow-up will occur after 7 days. The primary outcome measure will be post-ERCP pancreatitis, and secondary outcome measures will be mild, moderate and severe pancreatitis; post procedure pancreatitis-related mortality; and adverse events.

Conditions

  • Pancreatitis

Interventions

  • glyceryl nitrateDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. acute pancreatitis within 7 days after the ERCP procedure. (An independent committee at each center will retrospectively judge whether patients have had post-ERCP pancreatitis or not in respect to a specific definition.)

Locations

14 sites in 4 countries. Site status is shown where the registry gives one.

  • Department of Medical and Surgical Gastroenterology, KAS Glostrup

    Copenhagen, Glostrup, Denmark

  • Dept. of Medical Gastroenterology F, KAS Gentofte

    Copenhagen, Hellerup, Denmark

  • Gastroenheden, Hvidovre Hospital

    Copenhagen, Hvidovre, Denmark

  • Rigshospitalet

    Copenhagen, København Ø, Denmark

  • Køge County Hospital

    Køge, Køge, Denmark

  • Dept of Medical Gastroenterology S, Odense Universitetshospital

    Odense, Odense, Denmark

  • North Hospital

    Marseille, Marseille, France

  • Serv Gastroenterologie Hopital Sainte Marguerite

    Marseille, Marseille Cedex 09, France

  • Div of Gastroenterology, dept. of Int Medicine Affiliated Hospital University of Oslo, Østfold Fredrikstad

    Fredrikstad, Fredrikstad, Norway

  • Helse Fonna HF Haugesund Sjukehus Kirurgisk - vest blokk gastro

    Haugesund, Haugesund, Norway

  • Ullevål Hospital

    Oslo, Oslo, Norway

  • Stavanger Hospital

    Stavanger, Stavanger, Norway

  • Halmstad Hospital

    Halmstad, Halmstad, Sweden

  • Dept of Surgery, University Hospital Malmö

    Malmö, Malmö, Sweden

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.